Você procurou por: acetylcholinesterase (Maltês - Inglês)

in vitro, dan il-metabolit juri inibizzjoni minima għal acetylcholinesterase (<10 %).
in vitro, this metabolite shows minimal inhibition of acetylcholinesterase (<10 %).

in vitro din is-sustanza turi inibizzjoni minima ta’ acetylcholinesterase (<10%).
in vitro, this metabolite shows minimal inhibition of acetylcholinesterase (<10%).

rivastigmine jaħdem billi jimblokka l-enzimi li jkissru acetylcholine: acetylcholinesterase u butyrylcholinesterase.
rivastigmine works by blocking the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase.

rivastigmine jaħdem billi jimblokka l-enzimi li jfarrku l- acetylcholine: acetylcholinesterase u butyrylcholinesterase.
rivastigmine works by blocking the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase.

in vitro din is-sustanza li tifforma fil-metaboliżmu turi inibizzjoni minima għal acetylcholinesterase (<10 %).
in vitro, this metabolite shows minimal inhibition of acetylcholinesterase (<10%).

19 kura minħabba li rivastigmine għandu half- life fil- plażma ta ’ xi siegħa, u l- inibizzjoni ta ’ acetylcholinesterase iddum xi 9 sigħat, huwa rrikkmandat li fil- każijiet ta ’ doża eċċessiva bla sintomi, m’ għandu jingħata l- ebda doża oħra ta ’ rivastigmine għall- 24 siegħa wara.
treatment as rivastigmine has a plasma half-life of about 1 hour and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose no further dose of rivastigmine should be administered for the next 24 hours.